Search

Learn how MSK helps patients receive brain tumor treatment, identify symptoms and signs of brain tumors, and be aware of causes and risk factors.

… If you’ve been diagnosed with a brain tumor, you are facing many decisions — choices that can be overwhelming and hard. Where should you go for care? What’s your first step?  At Memorial Sloan Kettering, our team of experts is dedicated to caring for people with brain tumors and finding new treatments

Our doctors and researchers are constantly seeking new and improved treatments for salivary gland cancer through our program of clinical trials.

… Doctors at Memorial Sloan Kettering are constantly working to improve treatment for salivary gland cancer through research studies called clinical trials. Participating in a clinical trial may give you access to treatments that are not widely available elsewhere. A clinical trial may offer you additional

We’re here to support your child’s emotional, social, physical, and educational needs and provide programs that offer him or her the chance to feel like a normal kid.

… We recognize that a diagnosis of cancer can be just as overwhelming, frightening, and upsetting for the entire family as it is for your child. We’ve cared for hundreds of children with neuroblastoma, and it’s our goal to help you in every way we can, whether it’s with medical treatments , social or emotional

Learn how MSK skin cancer experts treat squamous cell skin cancer with surgery, radiation therapy and other approaches.

… Most cases of squamous cell carcinoma can be cured when found early and treated properly. Today, many treatment options are available, and most are easily performed at a doctor’s office. Which treatment approach is best for you will depend on such things as whether the squamous cell skin cancer is high

Use our uterine leiomyosarcoma nomogram to calculate survival at five years after diagnosis. Results can help physicians and patients understand the patient’s prognosis.

… Our uterine leiomyosarcoma nomogram is an online tool that can be used to predict the chance of overall survival at five years after a diagnosis of uterine leiomyosarcoma, which is a type of uterine cancer. Who Can Use This Tool? Clinicians and patients in consultation with their physicians can use this

Memorial Sloan Kettering is a leader in developing new treatments for central nervous system (CNS) lymphoma.

… MSK has focused on studying central nervous system (CNS) lymphoma for more than 40 years. We are a leader in developing clinical trials for treating this disease. In the laboratory, we are conducting research to find new treatments for CNS lymphoma. We have collected almost 200 tumor samples and conducted

Our experts are ready to help with compassionate care and the most-advanced treatment available. Read about our approach and how we can help.

… Neurofibromatosis type 1 (NF1) is caused by a change (mutation or variant) in a gene. Most often, it’s diagnosed during childhood. NF1 is among the most common genetic disorders. It affects about 1 in every 3,000 people. MSK has experts who monitor (watch) and treat NF1. Our team will help you understand

If you or your loved one has been diagnosed with gestational trophoblastic disease, Memorial Sloan Kettering is ready to help. Find a doctor or clinical trial, and learn about our approach to treatment.

… Gestational trophoblastic disease (GTD) is a group of rare tumors that begin during a pregnancy.  These tumors start in the cells that would normally develop into the placenta, which connects the fetus to the uterus. The tumors typically are diagnosed in women at the early or late stages of childbearing

Find out about MSK’s expertise in treating primary liver cancer, from surgery to minimally invasive techniques such as Nanoknife.

… The outlook for people with primary liver cancer has never been better. Today, many people survive the disease. Memorial Sloan Kettering specialists have cared for more than 5,000 patients with various types of primary liver tumors over the past decade, from benign (noncancerous) tumors to rare types

After being treated for esophageal cancer at Memorial Sloan Kettering, you should continue to be monitored for any side effects or signs that the disease has returned.

… At Memorial Sloan Kettering, it’s one of our priorities to continue to check in with you once your active treatments are over. We want to be sure you’re healing well and managing any side effects of your treatment. We also need to watch for signs that your cancer is back. We offer complete follow-up